Vaccines for unconventional diseases represent a frontier in vaccine development, addressing emerging and non-traditional threats to global health. These unconventional diseases may include emerging infectious diseases, neglected tropical diseases, or diseases with complex, non-traditional causative agents. Research in this field focuses on innovative approaches to vaccine design and development, leveraging advancements in biotechnology, genomics, and immunology. mRNA vaccine technology, as demonstrated with COVID-19 vaccines, exemplifies a groundbreaking approach applicable to unconventional diseases. Neglected tropical diseases, often affecting marginalized populations, are gaining attention in vaccine research efforts, aiming to provide affordable and accessible solutions for diseases like dengue, Chagas disease, and leishmaniasis. The One Health approach, recognizing the interconnectedness of human, animal, and environmental health, guides efforts to address zoonotic diseases and unconventional threats at their source. Collaborative initiatives between researchers, governments, and global health organizations are essential to advancing vaccines for unconventional diseases. Ongoing research aims to broaden the scope of preventive measures, ensuring that vulnerable populations worldwide have access to effective vaccines against a diverse range of infectious threats.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan